相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance
William Matsui et al.
CANCER RESEARCH (2008)
Adoptive transfer of effector CD8(+) T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Donor lymphocyte infusion in the treatment of first Hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia:: A retrospective risk factors analysis and comparison with other strategies by the EBMT acute leukemia working party
Christoph Schmid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone
Jeffrey S. Miller et al.
BLOOD (2007)
Multiple myeloma: A prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment
Constantine S. Mitsiades et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Allogeneic stem-cell transplantation provides excellent results in advanced stage chronic myeloid leukemia with major cytogenetic response to pre-transplant imatinib therapy
Martin Weisser et al.
LEUKEMIA & LYMPHOMA (2007)
Allogeneic intrabone marrow-bone marrow transplantation plus donor lymphocyte infusion suppresses growth of colon cancer cells implanted in skin and liver of rats
Yasushi Koike et al.
STEM CELLS (2007)
Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years
Philippe Rousselot et al.
BLOOD (2007)
Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches
Jochen Greiner et al.
BLOOD (2006)
Host MHC class II+ antigen-presentirig cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions
Ronjon Chakraverty et al.
BLOOD (2006)
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid et al.
BLOOD (2006)
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe
L. Barkholt et al.
ANNALS OF ONCOLOGY (2006)
Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction
Mhairi Copland et al.
BLOOD (2006)
Molecular persistence of chronic myeloid leukemia caused by donor T cells specific for lineage-restricted maturation antigens not recognizing immature progenitor-cells
P. A. von dem Borne et al.
LEUKEMIA (2006)
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma
N. W. C. J. van de Donk et al.
BONE MARROW TRANSPLANTATION (2006)
Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia
JG Gribben et al.
BLOOD (2005)
Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation
BN Savani et al.
BONE MARROW TRANSPLANTATION (2005)
Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome
C Schmid et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers
M Cobbold et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells
CJ Wu et al.
CLINICAL CANCER RESEARCH (2005)
A new strategy for treatment of malignant tumor:: Intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion
Y Suzuki et al.
STEM CELLS (2005)
Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance
HW Wang et al.
BLOOD (2005)
Hematopoetic stem cell transplantation for solid tumors in Europe
A Gratwohl et al.
ANNALS OF ONCOLOGY (2004)
Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome
S Depil et al.
BONE MARROW TRANSPLANTATION (2004)
Dose-escalated donor lymphocyte inftisions following reduced intensity transplantation: toxicity, chimerism, and disease responses
KS Peggs et al.
BLOOD (2004)
Graft-versus-leukemia reactions in allogeneic chimeras
HJ Kolb et al.
BLOOD (2004)
Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells
S Appel et al.
BLOOD (2004)
Donor APCs are required for maximal GVHD but not for GVL
CC Matte et al.
NATURE MEDICINE (2004)
In-vivo generation of leukaemia-derived dendritic cells
HJ Kolb et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2004)
Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation
KE Herbert et al.
BONE MARROW TRANSPLANTATION (2004)
Graft-versus-lymphoma effects: Clinical review, policy proposals, and immunobiology
A Grigg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells:: the need for T cells early after transplantation to induce a graft-versus-lymphoma effect
B Glass et al.
BONE MARROW TRANSPLANTATION (2004)
Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo
AB Dietz et al.
BLOOD (2004)
Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation
C Schmid et al.
LEUKEMIA (2004)
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma
E Morris et al.
BLOOD (2004)
Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro
K Cwynarski et al.
LEUKEMIA (2004)
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma
MB Maris et al.
BLOOD (2004)
Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity
V Mailander et al.
LEUKEMIA (2004)
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants
SSB Randolph et al.
BLOOD (2004)
The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma
HM Lokhorst et al.
BLOOD (2004)
Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse
SJ Choi et al.
LEUKEMIA (2004)
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status:: implications of minimal residual disease measurement with quantitative PCR
M Ritgen et al.
BLOOD (2004)
Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer
MR Bishop et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Molecules and mechanisms of the graft-versus-leukaemia effect
M Bleakley et al.
NATURE REVIEWS CANCER (2004)
Syngeneic hematopoietic stem-cell transplantation for Non-Hodgkin's lymphoma: A comparison with allogeneic and autologous transplantation - The lymphoma working committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation
PJ Bierman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment
R Bhatia et al.
BLOOD (2003)
Human cytotoxic T lymphocytes specific for Wilms' tumor antigen-1 inhibit engraftment of leukemiainitiating stem cells in non-obese diabetic-severe combined immunodeficient recipients
LQ Gao et al.
TRANSPLANTATION (2003)
Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: Importance of allogeneic T cells
CA Huff et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: Limited efficacy of graft-versus-tumor activity
KS Peggs et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
SG O'Brien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia
WAE Marijt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-speciflic T cells
JJ Molldrem et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma
IF Khouri et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study
P Lewalle et al.
BONE MARROW TRANSPLANTATION (2003)
Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia
A Burchert et al.
BLOOD (2003)
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation
SP Robinson et al.
BLOOD (2002)
Increasing tumor antigen expression overcomes ignorance to solid tumors via crosspresentation by bone marrow-derived stromal cells
MT Spiotto et al.
IMMUNITY (2002)
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants
SM Davies et al.
BLOOD (2002)
The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation
DI Marks et al.
BLOOD (2002)
The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells
CA Klein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
An animal model for human cellular immunotherapy: specific eradication of human acute lymphoblastic leukemia by cytotoxic T lymphocytes in NOD/scid mice
BA Nijmeijer et al.
BLOOD (2002)
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose
C Guglielmi et al.
BLOOD (2002)
Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma
R Bellucci et al.
BLOOD (2002)
Acute graft-versus-host disease does not require alloantigen expression on host epithelium
T Teshima et al.
NATURE MEDICINE (2002)
Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation
E Olavarria et al.
BLOOD (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation
JE Levine et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon
RE Brouwer et al.
HUMAN IMMUNOLOGY (2002)
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies
P Corradini et al.
BLOOD (2002)
CD25(+) immunoregulatory T-cells of donor origin suppress alloreactivity after BMT
BD Johnson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein
RE Clark et al.
BLOOD (2001)
Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis
RE Brouwer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay
C Becker et al.
NATURE MEDICINE (2001)
T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect
E Alyea et al.
BLOOD (2001)
Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia
A Woiciechowsky et al.
LEUKEMIA (2001)
Donor leukocyte infusions for multiple myeloma
M Salama et al.
BONE MARROW TRANSPLANTATION (2000)
Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis
X Chen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions
BR Blazar et al.
JOURNAL OF IMMUNOLOGY (2000)
Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia
X Chen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome
S Shiobara et al.
BONE MARROW TRANSPLANTATION (2000)
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation
R Childs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Donor leukocyte infusions in acute lymphocytic leukemia
RH Collins et al.
BONE MARROW TRANSPLANTATION (2000)
CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNγ receptor expression by nonhematopoietic cells
ZH Qin et al.
IMMUNITY (2000)
The human UTY gene encodes a novel HLA-BS-restricted H-Y antigen
EH Warren et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
